GLENMARK PHARMACEUTICALS
Back to Income Statement
|
GLENMARK PHARMACEUTICALS Last 5 Year Profit Before Tax History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Profit Before Tax | ₹36 Cr | ₹240 Cr | ₹1,441 Cr | ₹1,382 Cr | ₹1,096 Cr |
What is the latest Profit Before Tax of GLENMARK PHARMACEUTICALS ?
Year | Profit Before Tax |
---|---|
Mar2025 | ₹36 Cr |
Mar2024 | ₹240 Cr |
Mar2023 | ₹1,441 Cr |
Mar2022 | ₹1,382 Cr |
Mar2021 | ₹1,096 Cr |
How is Profit Before Tax of GLENMARK PHARMACEUTICALS Trending?
Years | Profit Before Tax | % Change | |
---|---|---|---|
Mar2025 | ₹36 Cr | -84.78 | |
Mar2024 | ₹240 Cr | -83.36 | |
Mar2023 | ₹1,441 Cr | 4.25 | |
Mar2022 | ₹1,382 Cr | 26.13 | |
Mar2021 | ₹1,096 Cr | - |
Compare Profit Before Tax of peers of GLENMARK PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
GLENMARK PHARMACEUTICALS | ₹56,956.4 Cr | -1.2% | 4.2% | 22% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹391,368.0 Cr | 0.7% | -0.7% | -11% | Stock Analytics | |
DIVIS LABORATORIES | ₹160,631.0 Cr | NA | -1.6% | 12.1% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹123,641.0 Cr | 3.1% | -0.9% | 9.1% | Stock Analytics | |
CIPLA | ₹123,419.0 Cr | -2% | -4% | -5.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹109,176.0 Cr | -0.2% | 2.4% | 0% | Stock Analytics |
GLENMARK PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
GLENMARK PHARMACEUTICALS | -1.2% |
4.2% |
22% |
SENSEX | -0.3% |
0.1% |
-1% |
You may also like the below Video Courses